A blood metabolomics test predicts asthma attacks up to 5 years ahead by measuring inflammatory lipid and steroid ratios tied ...

Some 28 million Americans suffer from asthma attacks. Now, researchers have developed a new method that they say could ...

Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...

Researchers identified a blood-based metabolite ratio that predicts asthma exacerbations up to five years in advance. The ...

Following the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont ® Scientific Limited sponsored an informative webinar by Intermedical ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

People living with asthma could gain better access to digital tools to help them better manage their condition ...